Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ)
CNY 19.22
(0.26%)
CNY 19.22
(0.26%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 872.07 Million CNY | -0.64% |
| 2022 | 877.67 Million CNY | 18.77% |
| 2021 | 738.99 Million CNY | 31.83% |
| 2020 | 560.55 Million CNY | -12.15% |
| 2019 | 638.08 Million CNY | 80.44% |
| 2018 | 353.63 Million CNY | -8.91% |
| 2017 | 388.23 Million CNY | 52.32% |
| 2016 | 254.88 Million CNY | 100.7% |
| 2015 | 127 Million CNY | 408.0% |
| 2014 | 25 Million CNY | 8.7% |
| 2013 | 23 Million CNY | -25.81% |
| 2012 | 31 Million CNY | -11.43% |
| 2011 | 35 Million CNY | -57.32% |
| 2010 | 82 Million CNY | 134.29% |
| 2009 | 35 Million CNY | 250.0% |
| 2008 | 10 Million CNY | 42.86% |
| 2007 | 7 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 913.98 Million CNY | 4.81% |
| 2024 Q3 | 1.23 Billion CNY | -5.27% |
| 2024 Q2 | 1.3 Billion CNY | 42.97% |
| 2023 Q1 | 698.53 Million CNY | -20.41% |
| 2023 FY | 872.07 Million CNY | -0.64% |
| 2023 Q2 | 795.87 Million CNY | 13.93% |
| 2023 Q3 | 684.3 Million CNY | -14.02% |
| 2023 Q4 | 872.07 Million CNY | 27.44% |
| 2022 Q2 | 894.84 Million CNY | 28.11% |
| 2022 Q4 | 877.67 Million CNY | -12.93% |
| 2022 FY | 877.67 Million CNY | 18.77% |
| 2022 Q3 | 1 Billion CNY | 12.65% |
| 2022 Q1 | 698.47 Million CNY | -5.48% |
| 2021 Q4 | 738.99 Million CNY | 4.28% |
| 2021 Q1 | 740.45 Million CNY | 32.09% |
| 2021 FY | 738.99 Million CNY | 31.83% |
| 2021 Q2 | 740.23 Million CNY | -0.03% |
| 2021 Q3 | 708.69 Million CNY | -4.26% |
| 2020 Q1 | 770.1 Million CNY | 20.69% |
| 2020 Q2 | 663.17 Million CNY | -13.88% |
| 2020 FY | 560.55 Million CNY | -12.15% |
| 2020 Q4 | 560.55 Million CNY | 1.58% |
| 2020 Q3 | 551.83 Million CNY | -16.79% |
| 2019 Q2 | 541.95 Million CNY | 9.81% |
| 2019 Q1 | 493.55 Million CNY | 39.57% |
| 2019 FY | 638.08 Million CNY | 80.44% |
| 2019 Q4 | 638.08 Million CNY | 34.9% |
| 2019 Q3 | 473 Million CNY | -12.72% |
| 2018 Q1 | 324.69 Million CNY | -16.37% |
| 2018 Q4 | 353.63 Million CNY | -13.57% |
| 2018 Q3 | 409.17 Million CNY | 37.24% |
| 2018 FY | 353.63 Million CNY | -8.91% |
| 2018 Q2 | 298.15 Million CNY | -8.17% |
| 2017 Q3 | 396.76 Million CNY | 16.93% |
| 2017 Q2 | 339.3 Million CNY | 27.63% |
| 2017 Q1 | 265.84 Million CNY | 4.3% |
| 2017 FY | 388.23 Million CNY | 52.32% |
| 2017 Q4 | 388.23 Million CNY | -2.15% |
| 2016 Q1 | 131.5 Million CNY | 3.54% |
| 2016 Q2 | 231.96 Million CNY | 76.4% |
| 2016 Q3 | 230.42 Million CNY | -0.66% |
| 2016 Q4 | 254.88 Million CNY | 10.62% |
| 2016 FY | 254.88 Million CNY | 100.7% |
| 2015 Q4 | 127 Million CNY | -6.4% |
| 2015 Q2 | 143 Million CNY | 410.71% |
| 2015 Q1 | 28 Million CNY | 12.0% |
| 2015 FY | 127 Million CNY | 408.0% |
| 2015 Q3 | 135.68 Million CNY | -5.12% |
| 2014 Q1 | 17 Million CNY | -26.09% |
| 2014 FY | 25 Million CNY | 8.7% |
| 2014 Q2 | 13.5 Million CNY | -20.59% |
| 2014 Q4 | 25 Million CNY | 47.06% |
| 2014 Q3 | 17 Million CNY | 25.93% |
| 2013 Q2 | 27 Million CNY | 0.0% |
| 2013 Q3 | 27 Million CNY | 0.0% |
| 2013 Q1 | 27 Million CNY | -12.9% |
| 2013 Q4 | 23 Million CNY | -14.81% |
| 2013 FY | 23 Million CNY | -25.81% |
| 2012 Q1 | 35 Million CNY | 0.0% |
| 2012 Q2 | 33 Million CNY | -5.71% |
| 2012 Q3 | 33 Million CNY | 0.0% |
| 2012 FY | 31 Million CNY | -11.43% |
| 2012 Q4 | 31 Million CNY | -6.06% |
| 2011 Q3 | 28 Million CNY | 0.0% |
| 2011 Q1 | 11 Million CNY | -86.59% |
| 2011 Q2 | 28 Million CNY | 154.55% |
| 2011 Q4 | 35 Million CNY | 25.0% |
| 2011 FY | 35 Million CNY | -57.32% |
| 2010 Q2 | 25 Million CNY | 0.0% |
| 2010 FY | 82 Million CNY | 134.29% |
| 2010 Q4 | 82 Million CNY | 134.29% |
| 2010 Q3 | 35 Million CNY | 40.0% |
| 2009 FY | 35 Million CNY | 250.0% |
| 2009 Q4 | 35 Million CNY | 0.0% |
| 2008 FY | 10 Million CNY | 42.86% |
| 2007 FY | 7 Million CNY | 0.0% |